AML Today & Tomorrow: Current Care and Future Possibilities
An Acute myeloid leukemia (AML) diagnosis moves quickly, leaving you with little time to process a massive wave of medical information. It is completely natural to feel overwhelmed or anxious about what comes next. This 60-minute session is your space to find clarity and steady your footing. Led by an expert nurse practitioner, we strip away the clinical jargon to give you the practical knowledge you need right now. You will walk away feeling grounded, deeply supported, and fully equipped to speak confidently with your healthcare team.
What You Stand to Gain:
- Clarity Over Confusion: Master the basics of how AML behaves in the body using simple, gentle, everyday language. Understanding the science helps remove the fear of the unknown so you can make sense of your treatment plan.
- A Clear Map of Your Treatment Options: Demystify the clinical paths available today. Camille will provide a straightforward review of standard protocols—from intensive chemotherapy to the latest targeted therapies—so you know exactly how these treatments work and why your team might choose them.
- A Real Reason for Optimism: Discover how new molecules and precision medicine are changing the future of AML care. You will learn how these innovations are making treatments more precise, giving you and your family concrete reasons to feel hopeful.
- Live Q&A: Skip the stressful internet searches.
- Take advantage of a 15-minute open forum to get reliable answers directly from Camille.
Why This Webcast is For You:
- If you are living with AML: To ease the anxiety of a rapid medical protocol, gain control over your daily routine, and actively participate in your healing journey.
- If you are a caregiver: To understand exactly what your loved one is experiencing physically and emotionally, allowing you to track their progress safely and advocate for them at every step.
Camille Piquette, MN, RN, is a hematology nurse based in Calgary, Alberta, with more than 20 years of experience in hematologic malignancies. Throughout her career, she has worked in a variety of specialized settings, including bone marrow transplantation and clinical trials, contributing to both the delivery of complex cancer care and the advancement of research. Camille’s prior research examined the experiences of adults newly diagnosed with AML, with a focus on understanding how patients navigate the challenges of diagnosis and treatment decision making. Her professional interests include hematology, bone marrow transplantation, early phase clinical trials, palliative care, and advancing patient-centered care through research and evidence-informed practice.
This event was made possible thanks to the support of:
